Liz Down

1.4k total citations
23 papers, 485 citations indexed

About

Liz Down is a scholar working on Pulmonary and Respiratory Medicine, Oncology and General Health Professions. According to data from OpenAlex, Liz Down has authored 23 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in General Health Professions. Recurrent topics in Liz Down's work include Prostate Cancer Diagnosis and Treatment (9 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Prostate Cancer Treatment and Research (5 papers). Liz Down is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (9 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Prostate Cancer Treatment and Research (5 papers). Liz Down collaborates with scholars based in United Kingdom, United States and Spain. Liz Down's co-authors include David E. Neal, Freddie C. Hamdy, J. Athene Lane, Jenny Donovan, Chris Metcalfe, Richard M. Martin, Kerry Avery, Emma L. Turner, Eleanor Walsh and Michael Davis and has published in prestigious journals such as The Lancet Oncology, Journal of Clinical Epidemiology and British Journal of Cancer.

In The Last Decade

Liz Down

20 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liz Down United Kingdom 12 271 131 111 47 43 23 485
Prasad Bollina United Kingdom 11 231 0.9× 76 0.6× 74 0.7× 30 0.6× 42 1.0× 18 496
Lauren M. Hurwitz United States 13 171 0.6× 97 0.7× 72 0.6× 61 1.3× 53 1.2× 31 368
William Aiken Jamaica 14 261 1.0× 151 1.2× 82 0.7× 62 1.3× 20 0.5× 42 537
Sarah Goring United States 15 165 0.6× 154 1.2× 80 0.7× 33 0.7× 42 1.0× 37 613
Eleanor Walsh United Kingdom 10 192 0.7× 103 0.8× 75 0.7× 24 0.5× 26 0.6× 19 444
C Proudlove United Kingdom 11 126 0.5× 99 0.8× 60 0.5× 31 0.7× 12 0.3× 15 466
Sheray N. Chin Jamaica 11 99 0.4× 208 1.6× 115 1.0× 43 0.9× 19 0.4× 23 479
Álvaro Páez Spain 17 637 2.4× 207 1.6× 217 2.0× 68 1.4× 23 0.5× 52 926
J Bruin Rugge United States 5 302 1.1× 137 1.0× 81 0.7× 38 0.8× 69 1.6× 10 588
Christopher Quale United States 7 240 0.9× 148 1.1× 31 0.3× 107 2.3× 40 0.9× 10 538

Countries citing papers authored by Liz Down

Since Specialization
Citations

This map shows the geographic impact of Liz Down's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liz Down with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liz Down more than expected).

Fields of papers citing papers by Liz Down

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liz Down. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liz Down. The network helps show where Liz Down may publish in the future.

Co-authorship network of co-authors of Liz Down

This figure shows the co-authorship network connecting the top 25 collaborators of Liz Down. A scholar is included among the top collaborators of Liz Down based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liz Down. Liz Down is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Down, Liz, Sarah Bailey, Luke Mounce, et al.. (2025). Anaemia, ethnicity, and cancer incidence: a retrospective cohort study in primary care. British Journal of General Practice. 75(759). e678–e685. 2 indexed citations
2.
Chen, Ge, Liz Down, Luke Mounce, et al.. (2024). Exploring ethnic differences in the distribution of blood test results in healthy adult populations to inform earlier cancer detection: a systematic review. Family Practice. 41(5). 638–648. 1 indexed citations
4.
5.
Down, Liz, Luke Mounce, Garth Funston, et al.. (2024). The diagnostic performance of CA-125 for the detection of ovarian cancer in women from different ethnic groups: a cohort study of English primary care data. Journal of Ovarian Research. 17(1). 173–173.
6.
Down, Liz, Luke Mounce, Samuel WD Merriel, et al.. (2022). Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review. Prostate Cancer and Prostatic Diseases. 26(2). 249–256. 21 indexed citations
7.
Lane, J. Athene, Vanessa Er, Kerry Avery, et al.. (2018). ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer. Cancer Prevention Research. 11(11). 687–696. 33 indexed citations
9.
Lane, J. Athene, Jenny Donovan, Michael Davis, et al.. (2014). Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. The Lancet Oncology. 15(10). 1109–1118. 135 indexed citations
10.
Thorn, Joanna, Emma L. Turner, Luke Hounsome, et al.. (2014). Validation of The Hospital Episode Statistics Outpatient Dataset in England. Value in Health. 17(7). A547–A548. 1 indexed citations
11.
Avery, Kerry, Jenny Donovan, Rebecca Gilbert, et al.. (2013). Men with prostate cancer make positive dietary changes following diagnosis and treatment. Cancer Causes & Control. 24(6). 1119–1128. 32 indexed citations
12.
Down, Liz, Chris Metcalfe, Richard M. Martin, et al.. (2011). Seasonal variation in prostate‐specific antigen levels: a large cross‐sectional study of men in the UK. British Journal of Urology. 108(9). 1409–1414. 4 indexed citations
13.
Oxley, Jon, et al.. (2011). Clinicopathological and molecular study of penile melanoma. Journal of Clinical Pathology. 65(3). 228–231. 9 indexed citations
14.
Lane, J. Athene, Julia Wade, Liz Down, et al.. (2011). A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performance. Journal of Clinical Epidemiology. 64(6). 628–636. 13 indexed citations
15.
Lane, J. Athene, Liz Down, Julia Wade, et al.. (2011). Understanding factors influencing questionnaire response rates to maximise retention in a long term complex intervention trial. Trials. 12(S1). 6 indexed citations
16.
Down, Liz, George Davey Smith, Jenny Donovan, et al.. (2010). Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study). International Journal of Cancer. 128(6). 1442–1448. 32 indexed citations
17.
Macefield, Rhiannon, Chris Metcalfe, J. Athene Lane, et al.. (2010). Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. British Journal of Cancer. 102(9). 1335–1340. 71 indexed citations
18.
Macefield, Rhiannon, J. Athene Lane, Chris Metcalfe, et al.. (2009). Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?. European Journal of Cancer. 45(14). 2569–2573. 17 indexed citations
19.
Down, Liz, Chris Metcalfe, Kerry Avery, et al.. (2008). Factors distinguishing general practitioners who more readily participated in a large randomized trial were identified. Journal of Clinical Epidemiology. 62(1). 67–73. 9 indexed citations
20.
Lane, J. Athene, Joanne Howson, Jenny Donovan, et al.. (2007). Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial. BMJ. 335(7630). 1139–1139. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026